Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2008 AND VI 7 AND IP 5
Results: 23
1
2
The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.
- Published in:
- 2008
- By:
- Publication type:
- journal article
3
Demographic factors in the Chinese health-care market.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 383, doi. 10.1038/nrd2527
- By:
- Publication type:
- Article
4
High-throughput kinase profiling as a platform for drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 391, doi. 10.1038/nrd2541
- By:
- Publication type:
- Article
5
Aliskiren: the first renin inhibitor for clinical treatment.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 399, doi. 10.1038/nrd2550
- By:
- Publication type:
- Article
6
Cardiovascular disease: Spice might protect the heart.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 389, doi. 10.1038/nrd2576
- By:
- Publication type:
- Article
7
Targeting the endocannabinoid system: to enhance or reduce?
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 438, doi. 10.1038/nrd2553
- By:
- Publication type:
- Article
8
The way forward in HCV treatment — finding the right path.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
9
Autoimmune diseases: Targeting sugar coating.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 388, doi. 10.1038/nrd2573
- By:
- Publication type:
- Article
10
Antiparasitics: Fighting back against resistant worms.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 387, doi. 10.1038/nrd2574
- By:
- Publication type:
- Article
11
High-throughput screening: First fruits.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 388, doi. 10.1038/nrd2575
- By:
- Publication type:
- Article
12
Ranbaxy loses in Caduet dispute.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
13
Anticancer drugs: Scaffold to selectivity.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 390, doi. 10.1038/nrd2577
- By:
- Publication type:
- Article
14
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 390, doi. 10.1038/nrd2578
- Publication type:
- Article
15
Rilonacept.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 385, doi. 10.1038/nrd2579
- By:
- Publication type:
- Article
16
Clifford Rosen.
- Published in:
- 2008
- Publication type:
- Interview
17
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 371, doi. 10.1038/nrd2581
- Publication type:
- Article
18
Cardiovascular imaging in the light of ENHANCE.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 375, doi. 10.1038/nrd2583
- By:
- Publication type:
- Article
19
News in Brief.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 378, doi. 10.1038/nrd2585
- Publication type:
- Article
20
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 380, doi. 10.1038/nrd2586
- Publication type:
- Article
21
Paul Ehrlich: founder of chemotherapy.
- Published in:
- 2008
- By:
- Publication type:
- Biography
22
Of medicine and meta-analysis.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 376, doi. 10.1038/nrd2584
- Publication type:
- Article
23
Vaccine research.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 5, p. 457, doi. 10.1038/nrd2587
- By:
- Publication type:
- Article